Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2389-2395

  Massambu, Charles ^a,b   Pyakurel, Pawan ^b   Kaaya, Ephata ^a   Enbom, Malin ^b   Urassa, Willy ^a   Demirhan, Ilhan ^c,d   Loewer, Johannes ^c   Linde, Annika ^b   Chandra, Angelika ^d   Heiden, Thomas ^b,e   Doerr, Hans W ^d   Chandra, Prakash ^d   Biberfeld, Peter ^b  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b KAROLINSKA INSTITUTE   (Sweden)

^c PAUL EHRLICH INSTITUT   (Germany)

^d GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HHV8 genomes; HIV 1, HIV tat antibodies; Kaposi's sarcoma; Real time PCR

Indexed keywords

TRANSACTIVATOR PROTEIN; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPOSI SARCOMA; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL; SKIN BIOPSY;

ADULT; CHILD; DNA, VIRAL; FEMALE; GENE PRODUCTS, TAT; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; MALE; SARCOMA, KAPOSI; VIRAL LOAD;

EID: 0041304993     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Niedt GW, Myskowski PL, Urmacher C, Niedzwiecki D, Chapman D and Safai B: Histology of early lesions of AIDS-associated Kaposi's sarcoma. Mod Pathol 3(1): 64-70, 1990.
2. Kaaya EE, Parravicini C, Ordonez C, Gendelman R, Berti E, Gallo RC et al: Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol 10(3): 295-305, 1995.
3. Kaaya E, Castanos-Velez E, Heiden T, Ekman M, Catrina AI, Kitinya J et al: Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi's sarcoma. Med Oncol 17(4): 325-432, 2000.
4. Harawi S J: Kaposis's sarcoma. In: Harawi SJ, O'Hara CJ, ed. Pathology and Pathophysiology of AIDS and HIV-Related Diseases. London. Chapman and Hall Medical Ltd. 1989, pp 83-133.
5. Kaaya EE, Parravicini C, Sundelin B, Mgaya E, Kitinya J, Lema L et al: Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur J Cancer 28A(11): 1890-1894, 1992.
6. Bayley AC: Aggressive Kaposi's sarcoma in Zambia, 1983. Lancet 1(8390): 1318-1320, 1984.
7. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266(5192): 1865-1869, 1994.
8. Schalling M, Ekman M, Kaaya EE, Linde A and Biberfeld P: A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1(7): 707-708, 1995.
9. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A et al: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1(12): 1274-1278, 1995.
10. Gaidano G, Castanos-Velez E and Biberfeld P: Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions. Med Oncol 16(1): 8-12, 1999.
11. Cesarman E, Chang Y, Moore PS, Said JW and Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N Engl J Med 332(18): 1186-1191, 1995.
12. Blauvelt A: The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma. Adv Dermatol 14: 167-206; discussion 207, 1999.
13. Katano H, Sato Y, Kurata T, Mori S and Sata T: High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol 155(1): 47-52, 1999.
14. Moore PS and Chang Y: Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet 14(4): 144-150, 1998.
15. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A et al: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335(4): 233-241, 1996.
16. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J et al: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2(8): 925-928, 1996.
17. Chatlynne LG and Ablashi DV: Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 9(3): 175-185, 1999.
18. Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P et al: Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77(6): 817-820, 1998.
19. Campbell TB, Borok M, Gwanzura L, MaWhinney S, White IE, Ndemera B et al: Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. Aids 14(14): 2109-2116, 2000.
20. Lallemand F, Desire N, Rozenbaum W, Nicolas JC and Marechal V: Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 38(4): 1404-1408, 2000,
21. Mendez JC, Procop GW, Espy MJ, Paya CV and Smith TF: Detection and semiquantitative analysis of human herpesvirus 8 DNA in specimens from patients with Kaposi's sarcoma. J Clin Microbiol 36(8): 2220-2222, 1998.
22. Enbom M, Urassa W, Massambu C, Thorstensson R, Mhalu F and Linde A: Detection of human herpesvirus 8 DNA in serum from blood donors with HHV-8 antibodies indicates possible bloodborne virus transmission. J Med Virol 68(2): 264-267, 2002.
23. Albini A, Barillari G, Benelli R, Gallo RC and Ensoli B: Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 92(11): 4838-4342, 1995.
24. Goldstein G: HIV-1 Tat protein as a potential AIDS vaccine. Nat Med 2(9): 960-964, 1996.
25. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M et al: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371(6499): 674-680, 1994.
26. Demirhan I, Chandra A, Hasselmayer O and Chandra P: Intercellular traffic of human immunodeficiency virus type 1 transactivator protein defined by monoclonal antibodies. FEBS Lett 445(1): 53-56, 1999.
27. Demirhan I, Chandra A, Mueller F, Mueller H, Biberfeld P, Hasselmayer O et al: Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency virus type 1 infection and Kaposi's sarcoma. J Hum Virol 3(3): 137-143, 2000.
28. Demirhan I, Chandra A, Hasselmayer O, Biberfeld P and Chandra P: Detection of distinct patterns of anti-tat antibodies in HIV-infected individuals with or without Kaposi's sarcoma. J Acquir Immune Defic Syndr 22(4): 364-368, 1999.
29. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC and Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345(6270): 84-86, 1990.
30. Ensoli B and Sturzl M: Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9(1): 63-83, 1998.
31. Urassa W, Godoy K, Killewo J, Kwesigabo G, Mbakileki A, Mhalu F et al: The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania. J Clin Virol 14(1): 25-29, 1999.
32. Heid CA, Stevens J and Livak KJ and Williams PM: Real time quantitative PCR. Genome Res 6(70): 986-994, 1996.
33. Enbom M, Strand A, Falk KI and Linde A: Detection of Epstein-Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction. Sex Transm Dis 28(5): 300-306, 2001.
34. Monini P, Colombini S, Sturzl M, Goletti D, Cafaro A, Sgadari C et al: Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93(12): 4044-4058, 1999.
35. Kennedy MM, Cooper K, Howells DD, Picton S, Biddolph S, Lucas SB et al: Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesis. Mol Pathol 51(1): 14-20, 1998.
36. Schulz TF: Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 79(Pt 7): 1573-1591, 1998.
37. Lock MJ, Griffiths PD and Emery VC: Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8. J Virol Methods 64(1): 19-26, 1997.
38. Boivin G, Gaudreau A, Toma E, Lalonde R, Routy JP, Murray G et al: Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy. Antimicrob Agents Chemother 43(2): 377-380, 1999.
39. Boivin G, Gaudreau A and Routy JP: Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. Aids 14(13): 1907-1910, 2000.
40. Biberfeld P LC and Tschachler E and Luppi M: Human herpesvirus-8 and HIV. In: Viral Co-infections in HIV. Lalezari J and Moyle G. 2002.
41. Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM et al: The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 335(17): 1261-1269, 1996.
42. Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM et al: Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375(6526): 64-68, 1995.
43. Albini A, Paglieri I, Orengo G, Carlone S, Aluigi MG, DeMarchi R et al: The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. Aids 11(6): 713-721, 1997.